Lyell Immunopharma, Inc 10-K for FY2025
Lyell Immunopharma, Inc. (LYEL)
10-K
2026-03-12
For: 2025-12-31
View Original
Added on
April 12, 2026
About this 10-K
Lyell Immunopharma, Inc filed this 10-K on March 12, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $36K
- down 41.0% from $61K a year earlier
- Net loss
- $274.45M
- compared with a net loss of $342.99M a year earlier
- Diluted EPS
- -$16.06
- compared with -$26.23 a year earlier